COL6A1 and urinary bladder carcinoma: In addition, COL6A1 expression level was closely associated with immunotherapy in patients with advanced bladder cancer, and bladder cancer patients with high COL6A1 expression showed poorer responsiveness and efficacy to immunotherapy.